481 related articles for article (PubMed ID: 29107050)
21. Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Wang N; Kjellin H; Sofiadis A; Fotouhi O; Juhlin CC; Bäckdahl M; Zedenius J; Xu D; Lehtiö J; Larsson C
Oncotarget; 2016 Apr; 7(16):21332-46. PubMed ID: 26870890
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of long non coding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93/PTEN axis in colorectal cancer.
Wei H; Yang Z; Lin B
Gene; 2019 Mar; 687():9-15. PubMed ID: 30415006
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
24. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
Liu S; Song L; Zeng S; Zhang L
Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
[TBL] [Abstract][Full Text] [Related]
25. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
[TBL] [Abstract][Full Text] [Related]
26. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
[TBL] [Abstract][Full Text] [Related]
29. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
31. MALAT1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma.
Wang ML; Liu JX
J Cell Physiol; 2020 Feb; 235(2):1700-1710. PubMed ID: 31456244
[TBL] [Abstract][Full Text] [Related]
32. MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1.
Huang JK; Ma L; Song WH; Lu BY; Huang YB; Dong HM; Ma XK; Zhu ZZ; Zhou R
Biomed Pharmacother; 2016 Oct; 83():1-7. PubMed ID: 27470543
[TBL] [Abstract][Full Text] [Related]
33. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
[TBL] [Abstract][Full Text] [Related]
34. CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis.
Cordero-Barreal A; Caleiras E; López de Maturana E; Monteagudo M; Martínez-Montes ÁM; Letón R; Gil E; Álvarez-Escolá C; Regojo RM; Andía V; Marazuela M; Guadalix S; Calatayud M; Robles-Díaz L; Aguirre M; Cano JM; Díaz JÁ; Saavedra P; Lamas C; Azriel S; Sastre J; Aller J; Leandro-García LJ; Calsina B; Roldán-Romero JM; Santos M; Lanillos J; Cascón A; Rodríguez-Antona C; Robledo M; Montero-Conde C
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32791518
[TBL] [Abstract][Full Text] [Related]
35. Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.
Rodríguez-Antona C; Pallares J; Montero-Conde C; Inglada-Pérez L; Castelblanco E; Landa I; Leskelä S; Leandro-García LJ; López-Jiménez E; Letón R; Cascón A; Lerma E; Martin MC; Carralero MC; Mauricio D; Cigudosa JC; Matias-Guiu X; Robledo M
Endocr Relat Cancer; 2010 Mar; 17(1):7-16. PubMed ID: 19776290
[TBL] [Abstract][Full Text] [Related]
36. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.
Hua WF; Zhong Q; Xia TL; Chen Q; Zhang MY; Zhou AJ; Tu ZW; Qu C; Li MZ; Xia YF; Wang HY; Xie D; Claret FX; Song EW; Zeng MS
Cell Death Dis; 2016 Sep; 7(9):e2352. PubMed ID: 27584791
[TBL] [Abstract][Full Text] [Related]
37. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
39. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.
Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P
Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
